ATE248184T1 - Dns-sequenzen des humanen cytomegaloviruses - Google Patents
Dns-sequenzen des humanen cytomegalovirusesInfo
- Publication number
- ATE248184T1 ATE248184T1 AT96910560T AT96910560T ATE248184T1 AT E248184 T1 ATE248184 T1 AT E248184T1 AT 96910560 T AT96910560 T AT 96910560T AT 96910560 T AT96910560 T AT 96910560T AT E248184 T1 ATE248184 T1 AT E248184T1
- Authority
- AT
- Austria
- Prior art keywords
- dna sequences
- human
- cytomegaloviruse
- hcmv
- sequences
- Prior art date
Links
- 108091028043 Nucleic acid sequence Proteins 0.000 title abstract 2
- 206010011831 Cytomegalovirus infection Diseases 0.000 abstract 2
- 241000701024 Human betaherpesvirus 5 Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000002163 immunogen Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/414,926 US5721354A (en) | 1995-03-31 | 1995-03-31 | Human cytomegalovirus DNA sequences |
PCT/US1996/004100 WO1996030387A1 (en) | 1995-03-31 | 1996-03-26 | Novel human cytomegalovirus dna sequences |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE248184T1 true ATE248184T1 (de) | 2003-09-15 |
Family
ID=23643613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96910560T ATE248184T1 (de) | 1995-03-31 | 1996-03-26 | Dns-sequenzen des humanen cytomegaloviruses |
Country Status (11)
Country | Link |
---|---|
US (7) | US5721354A (de) |
EP (1) | EP0821693B1 (de) |
JP (1) | JP3658411B2 (de) |
AT (1) | ATE248184T1 (de) |
AU (1) | AU706234B2 (de) |
CA (1) | CA2215328C (de) |
DE (1) | DE69629674T2 (de) |
DK (1) | DK0821693T3 (de) |
ES (1) | ES2206569T3 (de) |
PT (1) | PT821693E (de) |
WO (1) | WO1996030387A1 (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721354A (en) * | 1995-03-31 | 1998-02-24 | Aviron | Human cytomegalovirus DNA sequences |
FR2762601B3 (fr) * | 1997-04-29 | 1999-06-04 | Bio Merieux | Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations |
FR2762600B1 (fr) * | 1997-04-29 | 1999-11-05 | Bio Merieux | Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utlisations |
WO2000034335A2 (en) * | 1998-12-04 | 2000-06-15 | Schering Corporation | 'death domain' containing receptors |
JP3877894B2 (ja) * | 1999-01-13 | 2007-02-07 | 三菱電機株式会社 | 車両用ブラシレス交流発電機 |
JP3581660B2 (ja) | 1999-04-30 | 2004-10-27 | ラ ホヤ インスティチュート フォー アラジー アンド イムノロジー | 潜伏ウイルスの再活性化を予防しウイルスの複製を制御するための方法 |
JP2003514520A (ja) * | 1999-11-05 | 2003-04-22 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 29個のヒト分泌タンパク質 |
GB0024283D0 (en) * | 2000-10-04 | 2000-11-15 | Inpharmatica Ltd | Novel proteins |
US6692954B1 (en) | 2000-11-03 | 2004-02-17 | The Scripps Research Institute | Generation of human cytomegalovirus yeast artificial chromosome recombinants |
US7204990B1 (en) * | 2000-11-28 | 2007-04-17 | Medimmune Vaccines, Inc. | Attenuation of cytomegalovirus virulence |
EP1370645A2 (de) * | 2001-03-22 | 2003-12-17 | Incyte Genomics, Inc. | Adenylyl- und guanylylcyclasen |
WO2004033490A2 (en) * | 2002-10-09 | 2004-04-22 | University College Cardiff Consultants Limited | Hcmv derived immunomodulatory polypeptide |
PT2311848E (pt) * | 2002-12-23 | 2013-10-03 | Vical Inc | Vacinas à base de polinucleótido optimizadas por codão contra a infecção do citomegalovírus humano |
GB0400965D0 (en) * | 2004-01-16 | 2004-02-18 | Glaxo Group Ltd | Promoter |
US8088902B2 (en) | 2004-04-05 | 2012-01-03 | The Rockefeller University | DNA virus microRNA and methods for inhibiting same |
WO2006004661A1 (en) * | 2004-06-25 | 2006-01-12 | Medimmune Vaccines, Inc. | Recombinant human cytomegalovirus and vaccines comprising heterologous antigens |
WO2013054199A2 (en) * | 2011-10-12 | 2013-04-18 | Novartis Ag | Cmv antigens and uses thereof |
US20200182884A1 (en) | 2016-06-27 | 2020-06-11 | Juno Therapeutics, Inc. | Method of identifying peptide epitopes, molecules that bind such epitopes and related uses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075213A (en) * | 1984-07-27 | 1991-12-24 | City Of Hope | Method for detection and prevention of human cytomegalovirus infection |
US5194256A (en) * | 1984-08-21 | 1993-03-16 | The Board Of Trustees Of The Leland Sanford Junior University | Purified human cytomegalovirus protein |
US5721354A (en) * | 1995-03-31 | 1998-02-24 | Aviron | Human cytomegalovirus DNA sequences |
-
1995
- 1995-03-31 US US08/414,926 patent/US5721354A/en not_active Expired - Lifetime
-
1996
- 1996-03-26 PT PT96910560T patent/PT821693E/pt unknown
- 1996-03-26 DE DE69629674T patent/DE69629674T2/de not_active Expired - Lifetime
- 1996-03-26 ES ES96910560T patent/ES2206569T3/es not_active Expired - Lifetime
- 1996-03-26 DK DK96910560T patent/DK0821693T3/da active
- 1996-03-26 AU AU53727/96A patent/AU706234B2/en not_active Ceased
- 1996-03-26 JP JP52958696A patent/JP3658411B2/ja not_active Expired - Fee Related
- 1996-03-26 AT AT96910560T patent/ATE248184T1/de active
- 1996-03-26 WO PCT/US1996/004100 patent/WO1996030387A1/en active IP Right Grant
- 1996-03-26 EP EP96910560A patent/EP0821693B1/de not_active Expired - Lifetime
- 1996-03-26 CA CA2215328A patent/CA2215328C/en not_active Expired - Lifetime
-
1997
- 1997-09-10 US US08/926,922 patent/US5925751A/en not_active Expired - Lifetime
-
1999
- 1999-02-18 US US09/253,682 patent/US6040170A/en not_active Expired - Lifetime
-
2000
- 2000-03-17 US US09/527,657 patent/US6291236B1/en not_active Expired - Lifetime
-
2001
- 2001-06-26 US US09/892,100 patent/US6635477B1/en not_active Expired - Lifetime
-
2003
- 2003-03-21 US US10/394,848 patent/US20040001850A1/en not_active Abandoned
-
2005
- 2005-12-05 US US11/293,112 patent/US7208165B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7208165B2 (en) | 2007-04-24 |
US20040001850A1 (en) | 2004-01-01 |
US5925751A (en) | 1999-07-20 |
EP0821693B1 (de) | 2003-08-27 |
EP0821693A4 (de) | 1999-09-08 |
JPH11503013A (ja) | 1999-03-23 |
ES2206569T3 (es) | 2004-05-16 |
US20060240446A1 (en) | 2006-10-26 |
DK0821693T3 (da) | 2003-12-22 |
US6040170A (en) | 2000-03-21 |
DE69629674D1 (de) | 2003-10-02 |
AU5372796A (en) | 1996-10-16 |
AU706234B2 (en) | 1999-06-10 |
US6291236B1 (en) | 2001-09-18 |
PT821693E (pt) | 2004-01-30 |
EP0821693A1 (de) | 1998-02-04 |
US6635477B1 (en) | 2003-10-21 |
DE69629674T2 (de) | 2004-07-08 |
CA2215328A1 (en) | 1996-10-03 |
CA2215328C (en) | 2011-05-31 |
JP3658411B2 (ja) | 2005-06-08 |
US5721354A (en) | 1998-02-24 |
WO1996030387A1 (en) | 1996-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE248184T1 (de) | Dns-sequenzen des humanen cytomegaloviruses | |
TR200806258T2 (tr) | Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler | |
DK0708772T3 (da) | Imidazo[4,5,-c]pyridin-4-aminer | |
AP2001002199A0 (en) | Novel streptococcus antigens | |
BG103977A (en) | Low molecular rotamase enzymic activity inhibitors | |
DE69633941D1 (de) | Nachweis von unterschieden in nukleinsäuren | |
DE59809260D1 (de) | Verfahren zur Herstellung von niedermolekularen Homopolymerisaten des N-Vinylpyrrolidons | |
NZ504669A (en) | Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents | |
AU1870597A (en) | Nucleic acid sequences of genes of the high mobility group proteins and uses thereof | |
DK0882132T3 (da) | Et kombineret humant cytomegalovirus-antigen og anvendelse heraf | |
HUP0001991A2 (hu) | Varicella Zoster vírus 63-as géntermékkel szembeni vakcinák | |
MX9806041A (es) | Proteina purificada sr-p70. | |
IL98273A0 (en) | Dna sequences,proteins having esterase activity coded by them,and use of such proteins | |
ATE315092T1 (de) | Acetylhydrolase des plättchen aktivierenden faktors, und entsprechendes gen | |
SE9602822D0 (sv) | New receptor | |
ATE341339T1 (de) | Zusammensetzungen von rekombinanten papillomavirus vakzinen | |
AU8156594A (en) | Non-A non-B sequences | |
ES2165358T3 (es) | Utilizaciones de la proteinquinasa de neurofilamento/tau pk40. | |
DE69838615D1 (de) | ppGpp-SYNTHETASE UND EXPRESSIONSSYSTEME ZUR VERBESSERTEN HERSTELLUNG VON PROTEINEN | |
DE60024977D1 (de) | Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen | |
CA2177600A1 (fr) | Sequences d'acides nucleiques regulatrices et utilisations | |
SE9604439D0 (sv) | New receptor | |
CA2347371A1 (en) | HEMATOPOIETIC REGULATION FACTORS AND METHODS OF USE | |
NZ330913A (en) | Antigens for preventing and reducing parasite infection and disease | |
ITVE950001V0 (it) | Concio in laterizio per la realizzazione di architravi laterocementizi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0821693 Country of ref document: EP |